These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 1613985)

  • 1. [Inhibition of serotonin-induced platelet aggregation by endothelins].
    Takada A; Takada Y
    Nihon Rinsho; 1992 Feb; 50(2):315-8. PubMed ID: 1613985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelins inhibit serotonin-induced platelet aggregation via a mechanism involving protein kinase C.
    Pietraszek MH; Takada Y; Takada A
    Eur J Pharmacol; 1992 Aug; 219(2):289-93. PubMed ID: 1425954
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MCI-9042, a new antiplatelet agent is a selective S2-serotonergic receptor antagonist.
    Hara H; Osakabe M; Kitajima A; Tamao Y; Kikumoto R
    Thromb Haemost; 1991 Apr; 65(4):415-20. PubMed ID: 2057925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Investigations on 5-HT₄ receptor expression and effects of tegaserod on human platelet aggregation in vitro.
    Serebruany VL; El Mouelhi M; Pfannkuche HJ; Rose K; Marro M; Angiolillo DJ
    Am J Ther; 2010; 17(6):543-52. PubMed ID: 19797939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional expression of the amplification reaction between serotonin and epinephrine on platelets.
    De Clerck F; Xhonneux B; de Chaffoy de Courcelles D
    J Cardiovasc Pharmacol; 1988; 11 Suppl 1():S1-5. PubMed ID: 2459505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protein kinase C inhibitor, chelerythrine, potentiates the adrenaline-mediated aggregation of human platelets through calcium influx.
    Shah BH; Shamim G; Khan S; Saeed SA
    Biochem Mol Biol Int; 1996 May; 38(6):1135-41. PubMed ID: 8739035
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of P2Y(1) and P2Y(12) receptor antagonists on platelet aggregation induced by different agonists in human whole blood.
    Storey RF; Newby LJ; Heptinstall S
    Platelets; 2001 Nov; 12(7):443-7. PubMed ID: 11674863
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein kinase C in the anti-aggregatory effects of endothelin-1 on human platelets.
    Touyz RM; Schiffrin EL
    Clin Sci (Lond); 1995 Mar; 88(3):277-83. PubMed ID: 7537639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelin-1 releases prostacyclin and inhibits ex vivo platelet aggregation in the anesthetized rabbit.
    Thiemermann C; Lidbury PS; Thomas GR; Vane JR
    J Cardiovasc Pharmacol; 1989; 13 Suppl 5():S138-41; discussion S142. PubMed ID: 2473289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative investigation of the effects of the immunosuppressants cyclosporine A, cyclosporine G, and FK-506 on platelet activation.
    Fernandes JB; Naik UP; Markell MS; Kornecki E
    Cell Mol Biol Res; 1993; 39(3):265-74. PubMed ID: 7507391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carbon monoxide released by CORM-3 inhibits human platelets by a mechanism independent of soluble guanylate cyclase.
    Chlopicki S; Olszanecki R; Marcinkiewicz E; Lomnicka M; Motterlini R
    Cardiovasc Res; 2006 Jul; 71(2):393-401. PubMed ID: 16713591
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The metalloprotease, NN-PF3 from Naja naja venom inhibits platelet aggregation primarily by affecting α2β1 integrin.
    Kumar MS; Girish KS; Vishwanath BS; Kemparaju K
    Ann Hematol; 2011 May; 90(5):569-77. PubMed ID: 20957364
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difference in inhibitory actions of products of the myeloperoxidase- catalyzed reaction on initial aggregation of activated platelets].
    Rpshchupkin DI; Berzhitskaia VV; Murina MA
    Biofizika; 1998; 43(2):323-8. PubMed ID: 9591107
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibitory effect of GR32191, a thromboxane receptor blocking drug, on human platelet aggregation, adhesion and secretion.
    Hornby EJ; Foster MR; McCabe PJ; Stratton LE
    Thromb Haemost; 1989 Jun; 61(3):429-36. PubMed ID: 2529661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serotonin receptor site in human platelets from control and chlorpromazine treated subjects.
    Oppenheim B; Hefez A; Youdim MB
    Prog Biochem Pharmacol; 1980; 16():119-32. PubMed ID: 7443729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is epinephrine-induced platelet aggregation autoregulated by its metabolic degradation products in vivo?
    Evangelou AM; Malamas MP; Vezyraki P; Karkabounas SC
    In Vivo; 1998; 12(3):321-5. PubMed ID: 9706478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of the alpha(2A)-adrenoceptor mediates deceleration of the deaggregation component of the response to ADP or 5-HT in human platelets in vitro.
    Maayani S; Schwarz T; Craddock-Royal B; Tagliente TM
    Platelets; 2001 Sep; 12(6):359-75. PubMed ID: 11672475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phosphatidylinositol 3-kinase inhibitor, wortmannin, inhibits 5-hydroxytryptamine-mediated potentiation of platelet aggregation induced by epinephrine.
    Shah BH; Saeed SA
    Res Commun Mol Pathol Pharmacol; 1995 Aug; 89(2):157-64. PubMed ID: 8556270
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of 5-hydroxytryptamine-potentiated aggregation of human blood platelets by 5-hydroxytryptamine receptor-blocking agents.
    Glusa E; Markwardt F
    Biomed Biochim Acta; 1984; 43(2):215-20. PubMed ID: 6732757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.